1-3 of 3
Elaine Jaffe, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma.

Kieron Dunleavy, M.D., John Janik, M.D., Juan Gea-Banacloche, M.D., Margaret Shovlin, B.S.N., Therese White, M.S.N., Neta Goldschmidt, M.D., Nicole Grant, M.P.H., Omer Koc, M.D., Stefania Pittaluga, M.D., Elaine Jaffe, M.D., Louis Staudt, M.D., Ph.D., Wyndham H. Wilson, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1385.
https://doi.org/10.1182/blood.V104.11.1385.1385
Published: 2004
Journal Articles

Abbreviated Treatment with Short-Course Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Is Highly Effective in AIDS-Related Lymphoma (ARL).

Kieron Dunleavy, M.D., Richard Little, M.D., Juan Gea-Banacloche, M.D., Nicole Grant, M.P.H., Seth Steinberg, Ph.D., Robert Yarchoan, M.D., Stefania Pittaluga, M.D., Elaine Jaffe, M.D., John Janik, M.D., Wyndham H. Wilson, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3111.
https://doi.org/10.1182/blood.V104.11.3111.3111
Published: 2004
Journal Articles

Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma.

Wyndham H. Wilson, M.D., Ph.D., Kieron Dunleavy, M.D., Stefania Pittaluga, M.D., Nicole Grant, M.P.H., Seth Steinberg, Ph.D., Mark Raffeld, M.D., Bruce Chabner, M.D., Michael Grossbard, M.D., Elaine Jaffe, M.D., Louis Staudt, M.D., Ph.D., John Janik, M.D.
Journal: Blood
Blood (2004) 104 (11): 159.
https://doi.org/10.1182/blood.V104.11.159.159
Published: 2004